489790:KRXHanwha Vision Co., Ltd. Analysis
Data as of 2026-08-01 - not real-time
₩42,000.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Hanwha Vision is trading at roughly KRW 42,000, well above its DCF‑derived fair value of KRW 23,231, implying a substantial premium. The stock sits below its 20‑day SMA (KRW 43,438) and far under the 50‑day (KRW 56,796) and 200‑day (KRW 60,130) averages, confirming a bearish price trend despite a bullish MACD signal (histogram +170) and a neutral RSI of 43.1. Volume remains stable, but volatility is extreme at 113% over the past 30 days, and the company has suffered a historic max drawdown of –64%, underscoring heightened price swings. Fundamentals are weak: revenue has contracted 2.3%, margins are thin (gross 52.6%, operating 5.0%, profit 1.9%), and the firm reports zero EPS with a forward PE of 1,174 versus an industry average of 31. Debt is high (KRW 683 bn) with a debt‑to‑equity ratio near 79, while cash balances are modest relative to liabilities. The market sentiment index reads “Extreme Greed” (92.9), yet the underlying financial health and valuation gaps suggest limited upside. Investors should therefore treat the current price as speculative and focus on the mismatch between market enthusiasm and the company’s earnings‑free, highly leveraged profile.
Given the bearish technical backdrop, the pronounced overvaluation, and the company’s inability to generate earnings, the long‑term outlook is negative. The short‑ to medium‑term may see brief buying interest from technical traders, but the structural risks – high leverage, zero dividend, and sector cyclicality – dominate. Caution is warranted, and any exposure should be limited to a tactical position rather than a core holding.
Given the bearish technical backdrop, the pronounced overvaluation, and the company’s inability to generate earnings, the long‑term outlook is negative. The short‑ to medium‑term may see brief buying interest from technical traders, but the structural risks – high leverage, zero dividend, and sector cyclicality – dominate. Caution is warranted, and any exposure should be limited to a tactical position rather than a core holding.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish price trend relative to moving averages
- Bullish MACD histogram suggesting limited upside
- Severe overvaluation versus DCF fair value
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Continued earnings void and high debt load
- Extreme market sentiment not supported by fundamentals
- High volatility and large historical drawdown
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Zero EPS and unsustainable debt‑to‑equity ratio
- Price far above fair value and industry PE multiples
- Weak revenue growth and thin profitability margins
Key Metrics & Analysis
Financial Health
Revenue Growth-2.30%
Profit Margin1.91%
P/E Ratio1174.3
Debt/Equity78.88
Op. Cash Flow₩177.2B
Industry P/E30.9
Technical Analysis
TrendBearish
RSI43.1
Support₩30,950.00
Resistance₩51,200.00
MA 20₩43,437.50
MA 50₩56,796.00
MA 200₩60,130.25
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
Fair Value₩23,230.83
Target Price₩77,500.00
Upside/Downside84.52%
GradeOvervalued
TypeValue
Risk Assessment
Beta0.69
Volatility112.98%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.